Innovative AI-based decision support system to improve therapies for patients with unresectable mCRC
| PROGRAMME | KEYWORDS | ROLE |
| Horizon 2020 | Artificial Intelligence, Predictive Algorythms, Biobanks, Oncology |
|
REVERT focuses on an innovative AI-based decision support system utilizing the experience and real-world data from several European general hospitals.
The main goal is to develop an improved and innovative model of combinatorial therapy that identifies the most efficient and cost-effective therapeutic intervention for patients with unresectable mCRC.
- 7 medical oncology units involved in the clinical trials
- 1 Predictive algorithm ‘trained’ through retrospective evaluation of the clinical profiles of patients
- Detailed analysis based on the study of consolidated data – which have been classified in the Revert database – on metastatic patients from European biobanks